METABOLIC SYNDROME – THE "SILENT KILLER", A CONTINUING CHALLENGE

Abstract

Metabolic syndrome, also known as dysmetabolic/plurimetabolic syndrome, X syndrome, insulinresistance syndrome or deadly quartet is an aggregate of interrelated metabolic abnormalities that occur with a higher prevalence in people with insulinresistance or with compensatory hyperinsulinism and identifies subjects who are at risk for developing type 2 diabetes and cardiovascular disease. In addition, individuals with metabolic syndrome are at increased risk of developing polycystic ovarian syndrome, non-alcoholic fatty liver, gallstones (cholesterol stones), sleep apnea, asthma and some forms of cancer.